Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about changes to terminology appears above the page, and the site revision label advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error and a minimal header, replacing the expected study-record content. A Home link is shown for navigation.SummaryDifference19%

- Check40 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, reflecting a new build of the page. This change represents a backend or frontend update rather than content changes for the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the page, indicating a small backend/software patch rather than a content change.SummaryDifference0.0%

- Check61 days agoChange DetectedA funding line noting the U.S. NIH Grant/Contract was added to the study record. This reflects government support for the trial.SummaryDifference0.0%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.